PolyPid Ltd. Cash and Cash Equivalents 2011-2026 | PYPD

Annual Cash and Cash Equivalents PolyPid Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	4.32 M	4.5 M	7.77 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
7.77 M	4.32 M	5.53 M

Quarterly Cash and Cash Equivalents PolyPid Ltd.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	9.82 M	-	7.45 M	-	4.32 M	-	-	-	3.92 M	-	-	-	7.77 M	-	-	-	4.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
9.82 M	3.92 M	6.23 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Adagene ADAG	75.2 M	$ 1.9	-3.11 %	$ 107 M	China
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
Aeterna Zentaris AEZS	16.4 M	-	5.93 %	$ 314 M	Canada
Alterity Therapeutics Limited ATHE	34.8 M	$ 3.31	-4.06 %	$ 7.96 B	Australia
AgeX Therapeutics AGE	345 K	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	89.4 M	-	-	$ 1.01 B	USA
Amphastar Pharmaceuticals AMPH	152 M	$ 25.87	-0.79 %	$ 1.25 B	USA
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	6.15 M	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
Athira Pharma ATHA	48.4 M	-	-	$ 269 M	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
AVROBIO AVRO	98 M	-	1083.1 %	$ 745 M	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Ascendis Pharma A/S ASND	560 M	$ 215.29	4.59 %	$ 5 B	Danmark
BioNTech SE BNTX	9.76 B	$ 105.97	-2.78 %	$ 27.2 B	Germany
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
Aytu BioScience AYTU	31 M	$ 2.71	1.88 %	$ 17 M	USA
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
Arrowhead Pharmaceuticals ARWR	227 M	$ 64.74	1.41 %	$ 8.66 B	USA
Brickell Biotech BBI	10.9 M	-	-5.38 %	$ 6.06 M	USA
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 3.96	-1.0 %	$ 8.62 B	Israel
BeiGene, Ltd. BGNE	2.63 B	-	0.49 %	$ 251 B	Cayman-islands
Burford Capital Limited BUR	322 M	$ 9.63	-0.93 %	$ 1.56 B	Britain
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Adaptimmune Therapeutics plc ADAP	144 M	-	-15.15 %	$ 60.3 M	Britain
AIkido Pharma AIKI	4.08 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
Acer Therapeutics ACER	2.33 M	-	2.71 %	$ 14 M	USA
Bellicum Pharmaceuticals BLCM	21.8 M	-	-9.72 %	$ 5.89 M	USA
Alpine Immune Sciences ALPN	13.4 M	-	-	$ 2.17 B	USA
AlloVir ALVR	118 M	-	4.14 %	$ 49.1 M	USA
BioLineRx Ltd. BLRX	10.4 M	$ 2.97	3.12 %	$ 908 M	Israel
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Biogen BIIB	2.38 B	$ 164.87	0.27 %	$ 24 B	USA
Bio-Path Holdings BPTH	1.05 M	-	-	$ 100 K	USA
BioVie BIVI	17.5 M	$ 1.23	2.07 %	$ 1.82 M	USA
Baudax Bio BXRX	5.26 M	-	0.59 %	$ 63 K	USA
Calithera Biosciences CALA	59.5 M	-	-10.95 %	$ 876 K	USA
Arena Pharmaceuticals ARNA	220 M	-	-6.81 %	$ 3.04 B	USA
Athersys ATHX	37.4 M	-	3.77 %	$ 22.4 M	USA
Cara Therapeutics CARA	51.8 M	-	-3.03 %	$ 260 M	USA
Avenue Therapeutics ATXI	2.59 M	-	-52.27 %	$ 4.45 M	USA